Narcan, the brand name for naloxone, is best known as an emergency overdose reversal drug, but it has several other medical uses. Because naloxone blocks opioid receptors throughout the body, not just in the brain, it can influence everything from gut function to itch signals to appetite. Some of these applications are well-established in clinical practice, while others remain investigational.
How Naloxone Works Beyond Overdose
Naloxone is an opioid receptor blocker. When someone overdoses, it knocks opioids off their receptors and reverses life-threatening breathing depression. But opioid receptors aren’t only involved in pain and sedation. Your body produces its own natural opioids (endorphins), and these molecules play roles in digestion, itch perception, blood pressure regulation, and even how you experience the pleasure of eating. By blocking those receptors, naloxone can interrupt processes that have nothing to do with drug use.
In someone with no opioids in their system, naloxone given at standard overdose-reversal doses has essentially no effect. The alternative uses described below work either because the patient is taking prescription opioids that cause side effects, or because the patient’s own endorphin system is contributing to a medical problem.
Opioid-Induced Constipation
This is one of the most common non-overdose uses. Opioid painkillers slow the gut dramatically, and constipation affects a large majority of patients on long-term opioid therapy. Standard laxatives often aren’t enough.
When naloxone is taken by mouth in small doses, most of it is broken down by the liver before reaching the bloodstream. That means it can block opioid receptors in the gut wall without undoing pain relief in the brain. Clinical protocols typically start at 2 mg taken three times daily, with a maximum of 4 mg three times daily. In published studies, all patients who received oral naloxone showed some improvement in bowel frequency.
The tricky part is dose balance. One researcher found that setting the naloxone dose at about 20% of the patient’s daily morphine dose provided effective relief for most people, but roughly 20% of those patients experienced some decrease in pain control. At higher naloxone doses, both the laxative effect and the risk of reversing pain relief increase. Some patients develop severe cramping or diarrhea, and in one clinical trial a patient on 4 mg naloxone experienced complete loss of pain relief along with diarrhea and anxiety on the second day.
Post-Surgical Bowel Slowdown
After abdominal surgery, the intestines often temporarily stop moving, a condition called post-operative ileus. Patients feel bloated, nauseated, and unable to eat, which delays recovery. When opioid painkillers given after surgery make the problem worse, oral naloxone is sometimes used to get the bowels moving again. Vanderbilt University Medical Center’s trauma protocol, for example, includes oral naloxone at 2 to 4 mg three times daily for up to 48 hours for patients on narcotics whose bowels haven’t resumed normal function.
Severe Itching From Liver Disease
People with cholestatic liver disease, where bile flow is blocked or impaired, often develop intense, unrelenting itching that doesn’t respond to antihistamines or moisturizers. This itching can be severe enough to disrupt sleep and daily life.
The cause appears to be an overload of the body’s own opioids. Patients with cholestatic pruritus have elevated levels of endogenous opioids, and these natural compounds act as an itch trigger. Blocking them with an opioid antagonist can bring relief. Both intravenous naloxone and oral naltrexone (a longer-acting relative) have proven effective in multiple studies and a meta-analysis reviewed by the American Association for the Study of Liver Diseases.
One complication: because these patients have chronically elevated endorphin levels, suddenly blocking those receptors can trigger a withdrawal-like reaction, with nausea, sweating, and agitation. Doctors typically start with very low doses and increase gradually to avoid this.
Binge Eating Disorder
Opioid receptors are part of the brain’s reward and pleasure circuitry, including the pleasure you get from eating. Researchers have tested whether blocking those receptors with naloxone changes eating behavior, particularly in people who binge eat.
In a study published in The American Journal of Clinical Nutrition, naloxone was given intravenously to 41 women, some with binge eating disorder and some without. The results were specific: naloxone suppressed the consumption of sweet, high-fat foods in binge eaters but had no effect on food intake in non-binge eaters. It also reduced how pleasurable the women rated the foods across all groups. The researchers concluded that while opioid blockade isn’t a useful weight-loss strategy for general obesity, it may help manage binge eating specifically. Naltrexone, the oral cousin of naloxone, is now part of an FDA-approved combination medication for weight management, building on this line of research.
Septic Shock
Septic shock causes dangerous drops in blood pressure as the body’s inflammatory response spirals out of control. Naloxone has been shown in some cases to produce a rise in blood pressure lasting up to several hours. The theory is that the body’s own endorphins, released during severe illness, contribute to the blood pressure collapse, and blocking them can partially reverse it.
However, this use remains limited and controversial. The FDA label for Narcan states directly that the blood pressure improvement “has not been demonstrated to improve patient survival.” Studies have also linked naloxone use in septic shock to agitation, pulmonary edema, dangerous heart rhythms, and seizures. Optimal dosing has never been established, and in one report involving two newborns in septic shock, one experienced a positive blood pressure response but later died after uncontrollable seizures.
Pain Perception Research
Naloxone has played a fascinating role in understanding how pain works. In a study of a patient with congenital insensitivity to pain, a rare condition where people cannot feel pain from birth, naloxone dramatically lowered the threshold at which the body’s pain reflexes activated. The patient’s pain reflex threshold was 350% higher than normal, but after naloxone, it dropped by 67% within two to three minutes, approaching normal levels.
The twist: even though the reflexes normalized, the patient still reported no sensation of pain. This finding helped researchers understand that congenital pain insensitivity involves both an overactive endorphin system and separate problems with how pain signals reach conscious awareness. Naloxone could fix one layer but not the other. While this hasn’t led to a clinical treatment, it revealed that the body’s natural opioid system plays a much larger role in pain regulation than previously understood.
Naloxone vs. Naltrexone for Non-Overdose Uses
You’ll notice naltrexone mentioned alongside naloxone in several of these uses. The two drugs block the same receptors with similar potency, but they differ in how they’re taken and how long they last. Naloxone is typically injected or given as a nasal spray and wears off within 30 to 90 minutes. Naltrexone is taken as a pill and lasts much longer, making it more practical for ongoing conditions like chronic itching, binge eating, or relapse prevention in addiction treatment.
For gut-related uses, oral naloxone has a unique advantage: the liver breaks most of it down before it reaches the rest of the body, concentrating its effects in the digestive tract. Naltrexone, by contrast, is designed to survive that process and reach the brain, which is why it’s preferred when the goal is blocking opioid receptors throughout the body.